165 related articles for article (PubMed ID: 22934705)
1. Upregulation of focal adhesion kinase by 14-3-3ε via NFκB activation in hepatocellular carcinoma.
Ko BS; Jan YJ; Chang TC; Liang SM; Chen SC; Liu TA; Wu YM; Wang J; Liou JY
Anticancer Agents Med Chem; 2013 May; 13(4):555-62. PubMed ID: 22934705
[TBL] [Abstract][Full Text] [Related]
2. Bortezomib suppresses focal adhesion kinase expression via interrupting nuclear factor-kappa B.
Ko BS; Chang TC; Chen CH; Liu CC; Kuo CC; Hsu C; Shen YC; Shen TL; Golubovskaya VM; Chang CC; Shyue SK; Liou JY
Life Sci; 2010 Jan; 86(5-6):199-206. PubMed ID: 20006625
[TBL] [Abstract][Full Text] [Related]
3. Focal adhesion kinase as a therapeutic target of bortezomib.
Ko BS; Chang TC; Liou JY
Anticancer Agents Med Chem; 2010 Dec; 10(10):747-52. PubMed ID: 21269258
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Significance of 14-3-3ε, Aldo-keto Reductase Family 1 B10 and Metallothionein-1 in Hepatocellular Carcinoma.
Wu CY; Jan YJ; Ko BS; Wu YJ; Wu YJ; Liou JY
Anticancer Res; 2018 Dec; 38(12):6855-6863. PubMed ID: 30504401
[TBL] [Abstract][Full Text] [Related]
5. 14-3-3ε overexpression contributes to epithelial-mesenchymal transition of hepatocellular carcinoma.
Liu TA; Jan YJ; Ko BS; Liang SM; Chen SC; Wang J; Hsu C; Wu YM; Liou JY
PLoS One; 2013; 8(3):e57968. PubMed ID: 23483955
[TBL] [Abstract][Full Text] [Related]
6. Regulation of aldo-keto-reductase family 1 B10 by 14-3-3ε and their prognostic impact of hepatocellular carcinoma.
Liu TA; Jan YJ; Ko BS; Wu YJ; Lu YJ; Liang SM; Liu CC; Chen SC; Wang J; Shyue SK; Liou JY
Oncotarget; 2015 Nov; 6(36):38967-82. PubMed ID: 26516929
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cells.
Chen KF; Yeh PY; Yeh KH; Lu YS; Huang SY; Cheng AL
Cancer Res; 2008 Aug; 68(16):6698-707. PubMed ID: 18701494
[TBL] [Abstract][Full Text] [Related]
8. [Focal adhesion kinase mRNA overexpression in hepatocellular carcinoma HCC) and correlation thereof with prognosis of HCC].
Yuan Z; Fan J; Wu ZQ; Zhou J; Qiu SJ
Zhonghua Yi Xue Za Zhi; 2007 May; 87(18):1256-9. PubMed ID: 17686260
[TBL] [Abstract][Full Text] [Related]
9. Capn4 contributes to tumour growth and metastasis of hepatocellular carcinoma by activation of the FAK-Src signalling pathways.
Dai Z; Zhou SL; Zhou ZJ; Bai DS; Xu XY; Fu XT; Chen Q; Zhao YM; Zhu K; Yu L; Yang GH; Wang Z; Wu WZ; Zhou J; Fan J
J Pathol; 2014 Nov; 234(3):316-28. PubMed ID: 24962955
[TBL] [Abstract][Full Text] [Related]
10. CADM2, as a new target of miR-10b, promotes tumor metastasis through FAK/AKT pathway in hepatocellular carcinoma.
Li D; Zhang Y; Zhang H; Zhan C; Li X; Ba T; Qiu Z; E F; Lv G; Zou C; Wang C; Si L; Zou C; Li Q; Gao X
J Exp Clin Cancer Res; 2018 Mar; 37(1):46. PubMed ID: 29506532
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of 14-3-3ε predicts tumour metastasis and poor survival in hepatocellular carcinoma.
Ko BS; Chang TC; Hsu C; Chen YC; Shen TL; Chen SC; Wang J; Wu KK; Jan YJ; Liou JY
Histopathology; 2011 Apr; 58(5):705-11. PubMed ID: 21401702
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin E₂ receptor EP1-mediated phosphorylation of focal adhesion kinase enhances cell adhesion and migration in hepatocellular carcinoma cells.
Bai X; Wang J; Zhang L; Ma J; Zhang H; Xia S; Zhang M; Ma X; Guo Y; Rong R; Cheng S; Shu W; Wang Y; Leng J
Int J Oncol; 2013 May; 42(5):1833-41. PubMed ID: 23525457
[TBL] [Abstract][Full Text] [Related]
13. Overexpressed focal adhesion kinase predicts a higher incidence of extrahepatic metastasis and worse survival in hepatocellular carcinoma.
Jan YJ; Ko BS; Hsu C; Chang TC; Chen SC; Wang J; Liou JY
Hum Pathol; 2009 Oct; 40(10):1384-90. PubMed ID: 19454363
[TBL] [Abstract][Full Text] [Related]
14. LncRNA DBH-AS1 facilitates the tumorigenesis of hepatocellular carcinoma by targeting miR-138 via FAK/Src/ERK pathway.
Bao J; Chen X; Hou Y; Kang G; Li Q; Xu Y
Biomed Pharmacother; 2018 Nov; 107():824-833. PubMed ID: 30142544
[TBL] [Abstract][Full Text] [Related]
15. Role of expression of focal adhesion kinase in progression of hepatocellular carcinoma.
Itoh S; Maeda T; Shimada M; Aishima S; Shirabe K; Tanaka S; Maehara Y
Clin Cancer Res; 2004 Apr; 10(8):2812-7. PubMed ID: 15102689
[TBL] [Abstract][Full Text] [Related]
16. Focal adhesion kinase activation limits efficacy of Dasatinib in c-Myc driven hepatocellular carcinoma.
Liu X; Song X; Zhang J; Xu Z; Che L; Qiao Y; Ortiz Pedraza Y; Cigliano A; Pascale RM; Calvisi DF; Liu Y; Chen X
Cancer Med; 2018 Dec; 7(12):6170-6181. PubMed ID: 30370649
[TBL] [Abstract][Full Text] [Related]
17. Quantitative proteomic dissection of a native 14-3-3ε interacting protein complex associated with hepatocellular carcinoma.
Bai C; Tang S; Bai C; Chen X
Amino Acids; 2014 Apr; 46(4):841-52. PubMed ID: 24363202
[TBL] [Abstract][Full Text] [Related]
18. Expression of Src and FAK in hepatocellular carcinoma and the effect of Src inhibitors on hepatocellular carcinoma in vitro.
Lau GM; Lau GM; Yu GL; Gelman IH; Gutowski A; Hangauer D; Fang JW
Dig Dis Sci; 2009 Jul; 54(7):1465-74. PubMed ID: 18979199
[TBL] [Abstract][Full Text] [Related]
19. Focal adhesion kinase confers lenvatinib resistance in hepatocellular carcinoma via the regulation of lysine-deficient kinase 1.
Hou W; Gad SA; Ding X; Dhanarajan A; Qiu W
Mol Carcinog; 2024 Jan; 63(1):173-189. PubMed ID: 37787401
[TBL] [Abstract][Full Text] [Related]
20. 14-3-3ε mediates the cell fate decision-making pathways in response of hepatocellular carcinoma to Bleomycin-induced DNA damage.
Tang S; Bao H; Zhang Y; Yao J; Yang P; Chen X
PLoS One; 2013; 8(3):e55268. PubMed ID: 23472066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
